BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. The company is headquartered in Chengdu, Sichuan and currently employs 323 full-time employees. The company went IPO on 2021-01-12. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The firm's main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.
最新の財務諸表(Form-10K)によると、BGM Group Ltdの総資産は$53で、純損失は$-1です。
BGMの主要な財務比率は何ですか?
BGM Group Ltdの流動比率は5.3、純利益率は-4、1株当たり売上高は$3.45です。
BGM Group Ltdの収益はセグメントまたは地域別にどのように分けられていますか?
BGM Group Ltd の最大収益セグメントは Oxytetracycline & Licorice Products and Traditional Chinese Medicine Derivatives で、最新の利益発表における収益は 21,961,282 です。地域別に見ると、China が BGM Group Ltd の主要市場であり、収益は 25,097,951 です。